Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

NCT00001765 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Chronic Granulomatous Disease

Interventions

DEVICE: Nexell Isolex with T-cell Depletion
DEVICE: Baxter isolex 300i

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)